Last reviewed 2026-04-22 · How we verify

Mixture of three Bifidobacteria

A mixture of three Bifidobacteria strains restores beneficial gut microbiota composition to promote intestinal health and immune function.

A mixture of three Bifidobacteria strains restores beneficial gut microbiota composition to promote intestinal health and immune function. Used for Dysbiosis and gastrointestinal disorders (specific indications not fully characterized in available literature).

At a glance

Mechanism of action

Bifidobacteria are commensal bacteria that colonize the colon and produce short-chain fatty acids, particularly butyrate, which strengthen the intestinal barrier, reduce pathogenic bacterial overgrowth, and modulate local and systemic immune responses. This probiotic mixture aims to restore eubiotic balance in dysbiotic conditions, improving gastrointestinal symptoms and potentially enhancing overall health outcomes.

Approved indications

• Dysbiosis and gastrointestinal disorders (specific indications not fully characterized in available literature)

Common side effects

• Gastrointestinal disturbance
• Bloating
• Flatulence

Key clinical trials

• Bifidobacteria In Children With Abdominal Pain-Associated Functional Gastrointestinal Disorders (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Mixture of three Bifidobacteria CI brief — competitive landscape report
• Mixture of three Bifidobacteria updates RSS · CI watch RSS
• Federico II University portfolio CI